AU5817096A - Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure - Google Patents

Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure

Info

Publication number
AU5817096A
AU5817096A AU58170/96A AU5817096A AU5817096A AU 5817096 A AU5817096 A AU 5817096A AU 58170/96 A AU58170/96 A AU 58170/96A AU 5817096 A AU5817096 A AU 5817096A AU 5817096 A AU5817096 A AU 5817096A
Authority
AU
Australia
Prior art keywords
enantiomers
heart failure
treating heart
dihydropyridine derivatives
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58170/96A
Inventor
Gianni Motta
Rodolfo Testa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Publication of AU5817096A publication Critical patent/AU5817096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
AU58170/96A 1995-05-12 1996-05-09 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure Abandoned AU5817096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT95MI000956A IT1279529B1 (en) 1995-05-12 1995-05-12 PROCEDURE FOR PREPARATION AND USE OF ENANTIOMERS (S) OF 1,4-DIHYDROPYRIDINE DERIVATIVES FOR THE TREATMENT OF HEART INSUFFICIENCY
ITMI95A0956 1995-05-12
PCT/EP1996/001978 WO1996035420A1 (en) 1995-05-12 1996-05-09 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure

Publications (1)

Publication Number Publication Date
AU5817096A true AU5817096A (en) 1996-11-29

Family

ID=11371580

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58170/96A Abandoned AU5817096A (en) 1995-05-12 1996-05-09 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure

Country Status (5)

Country Link
EP (1) EP0825862A1 (en)
JP (1) JP2000514776A (en)
AU (1) AU5817096A (en)
IT (1) IT1279529B1 (en)
WO (1) WO1996035420A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
WO1996035420A1 (en) 1996-11-14
IT1279529B1 (en) 1997-12-16
ITMI950956A0 (en) 1995-05-12
JP2000514776A (en) 2000-11-07
EP0825862A1 (en) 1998-03-04
ITMI950956A1 (en) 1996-11-12

Similar Documents

Publication Publication Date Title
AU695664B2 (en) Method for treating cardiac inflammatory disease
AU5437396A (en) Bileaflet heart valve
AU6913796A (en) Patient treatment apparatus
AU6275796A (en) Skin treatment process using laser
AU6379796A (en) Suture protector for prosthetic heart valve
AU6517196A (en) Piperazine derivatives as therapeutic agents
AU6029696A (en) Adjustable sizing apparatus for heart annulus
AU6094996A (en) Diphosphonate derivatives of therapeutic agents
AU5487696A (en) Apparatus for cardiac ablation
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5235896A (en) Ready-to-assemble casket
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU6914296A (en) Left coronary artery catheter
AU1115095A (en) Treatment of cellulose
AU7267091A (en) Derivatives of 4-(aminomethyl)piperidine, their preparation and their therapeutic application
AU3968695A (en) Patient operated tonometers
AU6679796A (en) Desktop medical laser generator
AU2748895A (en) Medical nebuliser
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
PL322284A1 (en) Derivatives of aminoteralin useful in treating diseases of cardiovascular system
AU5339398A (en) Apparatus for cardiac treatment
AU7135996A (en) Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof
AU7854094A (en) Use of amiodarone for the treatment of heart failure